Weight gain may contribute to increased fracture risk in women treated with rosiglitazone.
Pasco
J A
JA
Henry
M J
MJ
Nicholson
G C
GC
D000818:Animals; D048909:Diabetes Complications / Q000503:physiopathology*; D005260:Female; D050723:Fractures, Bone / Q000139:chemically induced; D006801:Humans; D051379:Mice; D008875:Middle Aged; D009765:Obesity / Q000150:complications*; D051381:Rats; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology
D045162:Thiazolidinediones; D000077154:Rosiglitazone